Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel; NHLBI Outstanding Investigator Award (OIA)—R35.                    

*Date:*                         August 4-5, 2021.                    

*Time:*                         11:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting).                    

*Contact Person:*                         Kristen Page, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 209-B, Bethesda, MD 20892, (301) 827-7953,                         *kristen.page@nih.gov*.                    

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel; Catalyze Enabling Technologies.                    

*Date:*                         August 18, 2021.                    

*Time:*                         11:00 a.m. to 2:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting).                    

*Contact Person:*                         Kristin Goltry, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 209-B, Bethesda, MD 20892, (301) 435-0297,                         *goltrykl@mail.nih.gov*.                    

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel; Catalyze Product Definition.                    

*Date:*                         August 19, 2021.                    

*Time:*                         11:00 a.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications and/or proposals.                    

*Place:*                         National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting).                    

*Contact Person:*                         Kristin Goltry, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 209-B, Bethesda, MD 20892, (301) 435-0297,                         *goltrykl@mail.nih.gov*.                    

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel; Early Stage Investigatory (EIA) R35 Review Meeting.                    

*Date:*                         August 25, 2021.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                              ( print page 33721)    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting).                    

*Contact Person:*                         Tony L. Creazzo, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 207-Q, Bethesda, MD 20892-7924, (301) 827-7913,                         *creazzotl@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) 

Dated: June 21, 2021.

David W. Freeman, 

Program Analyst, Office of Federal Advisory Committee Policy. 

[FR Doc. 2021-13527 Filed 6-24-21; 8:45 am]

BILLING CODE 4140-01-P